Spain · Delayed Price · Currency is EUR Natac Natural Ingredients Statistics
Total Valuation
BME:NAT has a market cap or net worth of EUR 248.29 million. The enterprise value is 310.17 million.
| Market Cap | 248.29M |
| Enterprise Value | 310.17M |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:NAT has 431.81 million shares outstanding.
| Current Share Class | 431.81M |
| Shares Outstanding | 431.81M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.39% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 232.04 and the forward PE ratio is 28.75. BME:NAT's PEG ratio is 0.70.
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | 232.04 |
| Forward PE | 28.75 |
| PS Ratio | 5.19 |
| PB Ratio | 5.52 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 65.51 |
| PEG Ratio | 0.70 |
Enterprise Valuation
| EV / Earnings | 289.87 |
| EV / Sales | 6.49 |
| EV / EBITDA | 26.71 |
| EV / EBIT | 74.48 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.58, with a Debt / Equity ratio of 1.41.
| Current Ratio | 0.58 |
| Quick Ratio | 0.28 |
| Debt / Equity | 1.41 |
| Debt / EBITDA | 5.45 |
| Debt / FCF | -8.40 |
| Interest Coverage | 0.89 |
Financial Efficiency
Return on equity (ROE) is 2.44% and return on invested capital (ROIC) is 1.88%.
| Return on Equity (ROE) | 2.44% |
| Return on Assets (ROA) | 1.89% |
| Return on Invested Capital (ROIC) | 1.88% |
| Return on Capital Employed (ROCE) | 4.59% |
| Weighted Average Cost of Capital (WACC) | 1.48% |
| Revenue Per Employee | 259,920 |
| Profits Per Employee | 5,815 |
| Employee Count | 171 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 0.90 |
Taxes
In the past 12 months, BME:NAT has paid 1.12 million in taxes.
| Income Tax | 1.12M |
| Effective Tax Rate | 51.22% |
Stock Price Statistics
The stock price has decreased by -21.92% in the last 52 weeks. The beta is -0.60, so BME:NAT's price volatility has been lower than the market average.
| Beta (5Y) | -0.60 |
| 52-Week Price Change | -21.92% |
| 50-Day Moving Average | 0.63 |
| 200-Day Moving Average | 0.73 |
| Relative Strength Index (RSI) | 39.54 |
| Average Volume (20 Days) | 23,595 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:NAT had revenue of EUR 47.83 million and earned 1.07 million in profits.
| Revenue | 47.83M |
| Gross Profit | 32.66M |
| Operating Income | 4.16M |
| Pretax Income | 2.19M |
| Net Income | 1.07M |
| EBITDA | 11.61M |
| EBIT | 4.16M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 1.40 million in cash and 63.29 million in debt, with a net cash position of -61.88 million or -0.14 per share.
| Cash & Cash Equivalents | 1.40M |
| Total Debt | 63.29M |
| Net Cash | -61.88M |
| Net Cash Per Share | -0.14 |
| Equity (Book Value) | 45.00M |
| Book Value Per Share | n/a |
| Working Capital | -21.25M |
Cash Flow
In the last 12 months, operating cash flow was 3.79 million and capital expenditures -11.32 million, giving a free cash flow of -7.53 million.
| Operating Cash Flow | 3.79M |
| Capital Expenditures | -11.32M |
| Depreciation & Amortization | 7.45M |
| Net Borrowing | n/a |
| Free Cash Flow | -7.53M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 68.30%, with operating and profit margins of 8.71% and 2.24%.
| Gross Margin | 68.30% |
| Operating Margin | 8.71% |
| Pretax Margin | 4.59% |
| Profit Margin | 2.24% |
| EBITDA Margin | 24.29% |
| EBIT Margin | 8.71% |
| FCF Margin | n/a |
Dividends & Yields
BME:NAT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.43% |
| FCF Yield | -3.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |